| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/31/2002 | WO2002008407A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/31/2002 | WO2002008404A2 Production of lysosomal enzymes in plants by transient expression |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008390A2 Bovine wasting syndrome vaccine |
| 01/31/2002 | WO2002008384A2 Novel glutamate transporters |
| 01/31/2002 | WO2002008383A2 Sp110, a polypeptide component of the nuclear body |
| 01/31/2002 | WO2002008382A2 Controlled environment agriculture bioreactor for heterologous protein production |
| 01/31/2002 | WO2002008381A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 01/31/2002 | WO2002008290A1 Dog melanin-concentrating hormone receptor |
| 01/31/2002 | WO2002008289A2 Novel proteins and nucleic acids encoding same |
| 01/31/2002 | WO2002008288A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008283A2 Lp120 polypeptides and therapeutic uses thereof |
| 01/31/2002 | WO2002008282A2 Bstp-ras/rerg protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008281A2 Bstp-cad protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008280A2 SCREENING METHODS BASED ON SUPERACTIVATED αVβ3 INTEGRIN |
| 01/31/2002 | WO2002008279A2 B7-h2 molecules, novel members of the b7 family and uses thereof |
| 01/31/2002 | WO2002008278A2 Compositions and methods relating to lung specific genes |
| 01/31/2002 | WO2002008277A2 Nucleic acids, vectors, host cells, polypeptides, and uses thereof |
| 01/31/2002 | WO2002008276A1 Human prothrombin kringle with endothelial cell growth inhibitory activity, vector and host thereof |
| 01/31/2002 | WO2002008275A2 Genes expressed in obese rat hypothalamus |
| 01/31/2002 | WO2002008272A2 High affinity soluble interleukin-18 receptor |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008270A2 A mort-1 interacting protein, its preparation and use |
| 01/31/2002 | WO2002008268A2 Leucine-based motif and clostridial neurotoxins |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008266A2 Complete nucleotide sequence of staphylococcus aureus ribosomal protein s16 gene and methods for the identification of antibacterial substances |
| 01/31/2002 | WO2002008265A2 Staphylococcus aureus ribosomal protein s20, corresponding gene and methods for the identification of antibacterial substances |
| 01/31/2002 | WO2002008263A2 Modified virus having an altered tropism |
| 01/31/2002 | WO2002008262A2 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008261A2 Bstp-trans protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008260A2 Bstp-ecg1 protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008259A2 Human cytokine receptor |
| 01/31/2002 | WO2002008258A2 65494, a human g-protein-coupled receptor family member and uses thereof |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008254A1 Compositions and methods for cancer screening |
| 01/31/2002 | WO2002008253A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 01/31/2002 | WO2002008252A2 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | WO2002008251A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008250A2 Ghrelin antagonists |
| 01/31/2002 | WO2002008249A1 Method of purifying calcium ion-binding protein |
| 01/31/2002 | WO2002008247A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide |
| 01/31/2002 | WO2002008242A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | WO2002007813A1 Vaccines |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007763A2 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
| 01/31/2002 | WO2002007762A1 Human tumor necrosis factor receptors tr21 and tr22 |
| 01/31/2002 | WO2002007759A2 Clostridial toxin derivatives and methods for treating pain |
| 01/31/2002 | WO2002007756A1 MuO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS |
| 01/31/2002 | WO2002007754A2 New use |
| 01/31/2002 | WO2002007752A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate |
| 01/31/2002 | WO2002007751A1 Identification and isolation of novel polypeptides having pdz domains and methods of using same |
| 01/31/2002 | WO2002007750A1 Alpha-conotoxin peptides |
| 01/31/2002 | WO2002007740A2 Snake toxin and use thereof as a pharmaceutical |
| 01/31/2002 | WO2002007678A2 Mu-conopeptides |
| 01/31/2002 | WO2002007676A2 Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr) |
| 01/31/2002 | WO2002007675A2 Omega-conopeptides |
| 01/31/2002 | WO2002007646A2 Artificial vascular grafts, and methods of producing and using same |
| 01/31/2002 | WO2002007514A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 01/31/2002 | WO2001083693A8 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses |
| 01/31/2002 | WO2001083562A3 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001077321A3 Identification of a human gaba transporter |
| 01/31/2002 | WO2001074297A3 Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor |
| 01/31/2002 | WO2001068868A3 Alpha(iii) subunit of prolyl 4-hydroxylase |
| 01/31/2002 | WO2001068120A3 Uses of bombesin receptor 3 |
| 01/31/2002 | WO2001064871A3 MAMMALIAN PRO-α3(V) COLLAGEN CHAIN GENES |
| 01/31/2002 | WO2001064870A3 Mutated cyclin g1 protein |
| 01/31/2002 | WO2001062785A3 Protein and gene and their use for diagnosis and treatment of schizophrenia |
| 01/31/2002 | WO2001062784A3 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/31/2002 | WO2001061017A3 Modified cytokines for use in cancer therapy |
| 01/31/2002 | WO2001057075A3 Virulence genes, proteins, and their use |
| 01/31/2002 | WO2001057065A3 Combinatorial protein domains |
| 01/31/2002 | WO2001054472A3 Nucleic acids, proteins, and antibodies |
| 01/31/2002 | WO2001053479A3 Molecular switches ii |
| 01/31/2002 | WO2001052887A3 Vaccination against canine herpesvirus infection and vaccines |
| 01/31/2002 | WO2001049716A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 01/31/2002 | WO2001044284A3 Chimeric natriuretic peptides |
| 01/31/2002 | WO2001042792A3 Diagnosis of cervical cancer using marker proteins |
| 01/31/2002 | WO2001040473A3 Pseudomonas aeruginosa antigens |
| 01/31/2002 | WO2001040259A3 Monkey orexin 1 receptor |
| 01/31/2002 | WO2001039788A3 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 01/31/2002 | WO2001038550A3 Methods for altering the expression of hyphal-specific genes |
| 01/31/2002 | WO2001034801A3 Recombinant gelatin in vaccines |
| 01/31/2002 | WO2001031343A3 Diagnosis and therapy of cancer using sgp28-related molecules |
| 01/31/2002 | WO2001029085A3 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen v |
| 01/31/2002 | WO2001021836A3 Molecules for diagnostics and therapeutics |
| 01/31/2002 | WO2000072869A9 Methods for producing 5'-nucleic acid-protein conjugates |
| 01/31/2002 | WO2000066787A3 Growth hormone-regulatable liver genes and proteins, and uses thereof |
| 01/31/2002 | WO2000063410A9 Methods and compositions for transforming cells using site-specific recombination |
| 01/31/2002 | WO2000059941A9 Purposeful movement of human migratory cells away from an agent source |
| 01/31/2002 | WO2000057910A9 Attenuated dengue-4 virus vaccine |
| 01/31/2002 | WO2000056900A3 Promoter sequences derived from fusarium venenatum and uses thereof |
| 01/31/2002 | WO2000047219A3 Methods and reagents for treating glucose metabolic disorders |
| 01/31/2002 | US20020013958 Polynucleotides and polypeptides derived from corn seedling |